Trial Profile
A Randomized, Single-Dose, Placebo-Controlled, Double-Blind, 3-Way Crossover Study to Determine the Relative Abuse Potential of Intravenous Oxycodone Hydrochloride Alone or in Combination With Intravenous Naltrexone Hydrochloride in Opioid Experienced Non-Dependent Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
- Indications Pain
- Focus Adverse reactions
- Sponsors Pfizer
- 19 Feb 2015 New trial record